- Home
- PINE vs PALI Comparison
PINE vs PALI Comparison
Compare PINE & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PINE
- PALI
- Stock Information
- Founded
- PINE 2019
- PALI 1996
- Country
- PINE United States
- PALI United States
- Employees
- PINE N/A
- PALI N/A
- Industry
- PINE Real Estate Investment Trusts
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PINE Real Estate
- PALI Health Care
- Exchange
- PINE Nasdaq
- PALI Nasdaq
- Market Cap
- PINE 194.1M
- PALI 212.0M
- IPO Year
- PINE 2019
- PALI N/A
- Fundamental
- Price
- PINE $13.88
- PALI $1.74
- Analyst Decision
- PINE Strong Buy
- PALI Strong Buy
- Analyst Count
- PINE 5
- PALI 2
- Target Price
- PINE $18.30
- PALI $12.00
- AVG Volume (30 Days)
- PINE 83.3K
- PALI 18.0M
- Earning Date
- PINE 10-23-2025
- PALI 11-11-2025
- Dividend Yield
- PINE 8.23%
- PALI N/A
- EPS Growth
- PINE N/A
- PALI N/A
- EPS
- PINE N/A
- PALI N/A
- Revenue
- PINE $56,340,000.00
- PALI N/A
- Revenue This Year
- PINE $14.36
- PALI N/A
- Revenue Next Year
- PINE $0.76
- PALI N/A
- P/E Ratio
- PINE N/A
- PALI N/A
- Revenue Growth
- PINE 17.14
- PALI N/A
- 52 Week Low
- PINE $13.10
- PALI $0.53
- 52 Week High
- PINE $18.75
- PALI $4.32
- Technical
- Relative Strength Index (RSI)
- PINE 46.88
- PALI 62.89
- Support Level
- PINE $13.10
- PALI $1.66
- Resistance Level
- PINE $13.85
- PALI $1.90
- Average True Range (ATR)
- PINE 0.29
- PALI 0.34
- MACD
- PINE 0.04
- PALI 0.00
- Stochastic Oscillator
- PINE 70.13
- PALI 62.86
About PINE Alpine Income Property Trust Inc.
Alpine Income Property Trust Inc is a real estate investment trust (REIT) that owns and operates a high-quality portfolio of commercial net lease properties in the United States. The company's portfolio predominantly comprises single-tenant retail properties located in or near metropolitan statistical areas, or MSAs. It operates in two business segments: income properties, which derive maximum revenue, and commercial loans and investments.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.